The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneBoth MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in miceEffect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice.How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke.RRAS: A key regulator and an important prognostic biomarker in biliary atresia.α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.[Nle4, D-Phe7]-α-MSH Inhibits Toll-Like Receptor (TLR)2- and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype.Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.Neuropeptides: keeping the balance between pathogen immunity and immune toleranceMechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats.Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agentsMC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory ResponseApplications of the role of α-MSH in ocular immune privilege.The alpha-melanocyte stimulating hormone induces conversion of effector T cells into treg cellsThe Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids.Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model.Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Melanocortins, Melanocortin Receptors and Multiple Sclerosis.Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting.
P2860
Q21558407-694152C4-1083-4B3E-AABE-D36B387C4934Q28298659-68BF2E5E-D301-42B3-BAA5-64CA9BF08A9FQ33630050-4F7170EC-C0FB-43DD-A710-637F05FC1FD8Q33988240-9DC680B2-DBCB-4818-89C5-F9D81D2C009EQ34049621-8D9B40E9-1197-41D4-8D18-BD56F30E6B46Q34591240-B47590FD-E2D7-4ED4-A3B3-D4BAE6B9FD1BQ34627621-AEB8CEAC-B900-4CBB-B17A-5091D85D9772Q35629987-73EECFA1-442D-4A1B-A7F8-85845A3695D5Q35937668-8005AD26-5982-4C0B-9E6C-15426EFE1D4DQ36064675-87D5FD97-51BE-49D1-B998-CE023796B7BBQ36134548-FA1BC3AC-7133-482B-A632-C22D5D7CA238Q36158715-FBE4A239-DBFF-410F-AD68-794F2E276BE1Q36613389-607BFB7B-2F19-4DA3-84C0-7FA29737191EQ36706589-B2A8D808-1177-40C1-A8E2-55D4D4155753Q37206399-B2C2739B-156E-4E1E-B16E-D586D8ED1D20Q37439267-8414DFBD-0A89-4AAC-A3CC-B1FC8351838EQ37827463-82AEB709-72F0-4A6E-B722-71BAF288838BQ38501748-85CCDDBB-1730-4224-BC92-8D135C040D2EQ38710638-AC35A391-0005-49F3-B48B-32532DD074C9Q39223279-08678D32-2181-440E-A2CC-974726416CCBQ40474467-D3287AC1-9FD6-43EC-B12C-B81C3098BBB9Q41205365-9A24DF80-FFA9-4071-869D-3D24EBA49E8CQ41552761-81BCD73A-7372-48E9-B534-2DF64E0CED79Q48117321-BD2392A0-6C5D-4E3A-B6DF-B9A2EDC62CB4
P2860
The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The diminishment of experiment ...... g hormone (alpha-MSH) therapy.
@en
type
label
The diminishment of experiment ...... g hormone (alpha-MSH) therapy.
@en
prefLabel
The diminishment of experiment ...... g hormone (alpha-MSH) therapy.
@en
P2860
P1476
The diminishment of experiment ...... g hormone (alpha-MSH) therapy.
@en
P2093
Andrew W Taylor
Nobuyoshi Kitaichi
P2860
P304
P356
10.1016/J.BBI.2007.11.001
P577
2008-01-02T00:00:00Z